Predict your next investment

Medmisr company logo
INTERNET | Internet Software & Services / Accounting & Finance
medmisr.com

See what CB Insights has to offer

Stage

Seed | Alive

Total Raised

$30K

Valuation

$0000 

Last Raised

$30K | 3 yrs ago

About Medmisr

Medmisr is a digital third party administrator that provides medical claims management services for insurance companies, starting from the first medical point of services. Medmisr aims to reshape the medical insurance industry through eliminating the traditional claim form, offering a cost optimization solution with complete new user experience, connecting all stakeholders online and providing protection against fraud.

Medmisr Headquarter Location

Cairo,

Egypt

+20 235685855

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Medmisr

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medmisr is included in 3 Expert Collections, including Africa Fintech.

A

Africa Fintech

223 items

I

InsurTech

1,627 items

Companies and startups that use of technology to improve core and ancillary insurance operations. Companies in this collection are creating new product architectures, improving underwriting models, accelerating claims and creating a better customer experience

F

Fintech

10,749 items

Excludes US-based companies

Medmisr Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Medmisr Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.